uk life sciences
DESCRIPTION
Working with Industry - HCS as Catalysts of Technology Adoption Dr Darren Clark, CEO Medilink East Midlands. UK Life Sciences. Reproduced from HM Government’s Strength & Opportunity Report 2011. Regional Strengths. Med Tech Companies. 40 % of all companies. - PowerPoint PPT PresentationTRANSCRIPT
Working with Industry - HCS as Catalysts of Technology Adoption
Dr Darren Clark, CEOMedilink East Midlands
UK Life Sciences
Reproduced from HM Government’s Strength & Opportunity Report 2011
Regional StrengthsMed Tech Companies
Reproduced from HM Government’s Strength & Opportunity Report 2011
40% of all companies
+ Largest Biotech Cluster in East of England
Common Goal
1st Challenge:New Product Development
Identify customer need Identify solution Translate into product
Market to customerEverybody’s Happy
Traditional Markets
NPDin Healthcare
Clinician
PatientCommissioner
Trust
But who is the
customer for health products?
2nd Challenge:Complex Innovation Landscape
National
NICE
NIC
Researchers
UniversitiesResearchCouncils
IMRCs /Catapults
Companies
Medilinks
TSB/BIS CCGs
HealthTechnologies KTN
EUCOMED ABHI / BIVDA
NHS Trusts/doctors etcCLAHRC /
BRUs/ AHSC / HTCs
EU Commission
DH / NHS
FCO
Companies
Professional Institutions
International Regional
NIHR
NTAC
Medilink UK
Medilink Model
• Sector Specific
• Industry association
• Membership based
• Not-for-profit
• Geographical focus
• Facilitate collaborations:
Medilink UK
BioBusiness NIMedilink East Midlands Medilink North West Medilink South WestMediWalesMedilink West MidlandsMedilink Yorkshire & HumberSEHTA
›1,000 members
Working Together
Wealth Health
Wealth Health
HCS
Contact for Further Information
Dr Darren ClarkChief Executive
Medilink East MidlandsBioCity NottinghamPennyfoot Street
NottinghamNG1 1GF
Tel: 0115 912 4330Fax: 0115 912 4331
e-mail: [email protected]: www.medilinkem.com